TACOMA, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)GENEVA FOUNDATION, founded in 1993, is a mid-sized nonprofit in the Science & Technology sector that reported $70.8M in total revenue in fiscal year 2023.
GENEVA'S MISSION IS TO ADVANCE MILITARY MEDICINE THROUGH RESEARCH, DEVELOPMENT AND EDUCATION. GENEVA WAS ESTABLISHED IN 1993 TO FACILITATE MEDICAL RESEARCH IN MILITARY MEDICAL FACILITIES, INCLUDING RESEARCH PROPOSAL DEVELOPMENT AND PROGRAM MANAGEMENT SERVICES TO ADVANCE MEDICAL TREATMENTS AND SOLUTIONS FOR US SERVICE MEMBERS AND THEIR FAMILIES, VETERANS, AND THE GENERAL PUBLIC.
THE GENEVA FOUNDATION IS A NON-PROFIT THAT ADVANCES MILITARY MEDICINE THROUGH RESEARCH, DEVELOPMENT, AND EDUCATION. GENEVA IS PROUD TO HAVE MORE THAN 30 YEARS OF EXPERIENCE DELIVERING FULL-SPECTRUM...
THE GENEVA FOUNDATION IS A NON-PROFIT THAT ADVANCES MILITARY MEDICINE THROUGH RESEARCH, DEVELOPMENT, AND EDUCATION. GENEVA IS PROUD TO HAVE MORE THAN 30 YEARS OF EXPERIENCE DELIVERING FULL-SPECTRUM SCIENTIFIC, TECHNICAL, AND PROGRAM MANAGEMENT EXPERTISE AS WE AIM TO ENSURE OPTIMAL HEALTH FOR SERVICE MEMBERS AND THE COMMUNITIES THEY SERVE. AS A GLOBAL ORGANIZATION WITH OVER 50 LOCATIONS AND MORE THAN 400 EMPLOYEES, GENEVA IS COMMITTED TO OUR VISION TO LEAD THE WAY IN TRANSFORMING MILITARY MEDICINE TO SAVE LIVES WORLDWIDE. GENEVA CONTINUES TO EXPAND OUR RESEARCH SOLUTIONS THROUGH MULTI-DISCIPLINARY COLLABORATIONS WITHIN AND OUTSIDE THE DOD IN 35+ RESEARCH AREAS, INCLUDING INFECTIOUS DISEASE AND BIOSECURITY, OPERATIONAL MEDICINE, COMBAT CASUALTY CARE, REHABILITATIVE MEDICINE, AND BRAIN HEALTH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $70,831,465 | $70,484,252 | +0.0% |
| Expenses | $73,178,655 | $70,925,674 | +0.0% |
| Net Income | $-2,347,190 | $-441,422 | +4.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ELISE HUSZAR | PRESIDENT & CEO | 40.00 |
Officer
Director
|
$243,653 | $21,138 | $264,791 |
| NEIL VINING | BOARD CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LISA COHEN | BOARD SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JEFF WATTS | BOARD TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN HORNICK | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ROSS COLT | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KENT KESTER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN MILLER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE ROUSSEAU | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM RUGGELS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL BROWN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SHELLY MULLIN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| BARB HOLCOMB | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KENNETH BERTRAM | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA COHEN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| UZMA ALAM | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL HARTWIG | BOARD MEMBER (THRU 02/23) | 1.00 |
Director
|
$0 | $0 | $0 |
| MATT RUECKERT | CHIEF OPERATING OFFICER | 40.00 |
Officer
|
$198,674 | $25,816 | $224,490 |
| ANDRIY BATCHINSKY | PRINCIPLE INVESTIGATOR | 40.00 |
Highest
|
$291,713 | $30,505 | $322,218 |
| BRAD ISAACSON | PRINCIPLE INVESTIGATOR | 40.00 |
Highest
|
$221,902 | $9,790 | $231,692 |
| VICTORIA TEPE | NEUROSCIENTIST II | 40.00 |
Highest
|
$191,006 | $19,269 | $210,275 |
| DANIEL RHON | PRINCIPLE INVESTIGATOR | 40.00 |
Highest
|
$176,361 | $10,347 | $186,708 |
| NELSON HAGER | SENIOR MEDICAL ADVISOR | 32.00 |
Highest
|
$170,247 | $6,518 | $176,765 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $70,831,465 | $73,178,655 | $24,448,882 | $-2,347,190 |
| 2022 | $70,484,252 | $70,925,674 | $23,193,213 | $-441,422 |
| 2021 | $79,691,242 | $78,523,599 | $24,538,199 | $1,167,643 |
| 2020 | $67,148,605 | $65,388,092 | $26,807,231 | $1,760,513 |
| 2019 | $55,984,862 | $56,299,635 | $14,865,828 | $-314,773 |
| 2018 | $51,848,973 | $50,877,649 | $16,684,780 | $971,324 |
Compare GENEVA FOUNDATION with other nonprofits in Washington and across the country.